Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Journal of Hypertension|August 5, 2016
Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertensionDavid A Calhoun
Circulation|December 13, 2006
Aldosterone and cardiovascular disease: smoke and fireDavid A Calhoun
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertensionDavid A Calhoun
Journal of Clinical Hypertension (Greenwich, Conn.)|March 9, 2006
Resistant or difficult-to-treat hypertensionDavid A Calhoun
Circulation|September 1, 2016
Renal Nerve Denervation, Adherence, and Management of Resistant HypertensionDavid A Calhoun
Hypertension (Dallas, Tex. : 1979)|August 8, 2007
Is there an unrecognized epidemic of primary aldosteronism? ProDavid A Calhoun
American Journal of Hypertension|April 23, 2019
The Year in Clinical Hypertension From Other PagesDavid A Calhoun
Annual Review of Medicine|October 25, 2012
Hyperaldosteronism as a common cause of resistant hypertensionDavid A Calhoun
Current Hypertension Reports|April 29, 2010
Obstructive sleep apnea and hypertensionDavid A Calhoun
Korean Circulation Journal|October 11, 2016
Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment ResistanceDavid A Calhoun
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Journal of Hypertension|August 5, 2016
Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertensionDavid A Calhoun
Circulation|December 13, 2006
Aldosterone and cardiovascular disease: smoke and fireDavid A Calhoun
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertensionDavid A Calhoun
Journal of Clinical Hypertension (Greenwich, Conn.)|March 9, 2006
Resistant or difficult-to-treat hypertensionDavid A Calhoun
Circulation|September 1, 2016
Renal Nerve Denervation, Adherence, and Management of Resistant HypertensionDavid A Calhoun
Hypertension (Dallas, Tex. : 1979)|August 8, 2007
Is there an unrecognized epidemic of primary aldosteronism? ProDavid A Calhoun
American Journal of Hypertension|April 23, 2019
The Year in Clinical Hypertension From Other PagesDavid A Calhoun
Annual Review of Medicine|October 25, 2012
Hyperaldosteronism as a common cause of resistant hypertensionDavid A Calhoun
Current Hypertension Reports|April 29, 2010
Obstructive sleep apnea and hypertensionDavid A Calhoun
Korean Circulation Journal|October 11, 2016
Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment ResistanceDavid A Calhoun
Pageof 19